Table 2.
Vero cell population (%) | ||||
---|---|---|---|---|
Treatment | Sub-G1 | G0/G1 | S | G2/M |
0 μg/mL TcCaNB | 8.1 ± 1.4 | 48.6 ± 3.9 | 11.1 ± 2.3 | 19.5 ± 1.5 |
5 μg/mL TcCaNB | 8.3 ± 1.0 | 53.2 ± 2.9 | 10.6 ± 1.5 | 16.7 ± 4.2 |
10 μg/mL TcCaNB | 8.9 ± 0.1 | 52.0 ± 1.3 | 10.7 ± 2.1 | 16.2 ± 0.9 |
20 μg/mL TcCaNB | 9.9 ± 2.2 | 52.5 ± 2.8 | 9.7 ± 0.9 | 14.7 ± 2.4 |
Note: Percentage of Vero cell population distributed in the phases of the cell cycle.